Lineage Cell Therapeutics, Inc 10-K for FY2025
Lineage Cell Therapeutics, Inc. (LCTX)
10-K
2026-03-05
For: 2025-12-31
View Original
Added on
April 12, 2026
About this 10-K
Lineage Cell Therapeutics, Inc filed this 10-K on March 5, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $14.56M
- up 53.2% from $9.5M a year earlier
- Net loss
- $63.53M
- compared with a net loss of $18.61M a year earlier
- Diluted EPS
- -$0.28
- compared with -$0.09 a year earlier